Wolfe Research Initiates Coverage On Abiomed with Peer Perform Rating, Announces Price Target of $330
Wolfe Research analyst Mike Polark initiates coverage on Abiomed (NASDAQ:ABMD) with a Peer Perform rating and announces Price Target of $330.
SVB Leerink Maintains Market Perform on Abiomed, Lowers Price Target to $325
SVB Leerink analyst Danielle Antalffy maintains Abiomed (NASDAQ:ABMD) with a Market Perform and lowers the price target from $345 to $325.
Earnings Scheduled For February 3, 2022
Companies Reporting Before The Bell
• Tuesday Morning (NASDAQ:TUEM) is likely to report earnings for its second quarter.
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower.
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Earnings Scheduled For October 28, 2021
Companies Reporting Before The Bell
• LendingTree (NASDAQ:TREE) is estimated to report quarterly earnings at $0.57 per share on revenue of $292.63 million.
Abiomed’s Earnings Outlook
Abiomed (NASDAQ:ABMD) is set to give its latest quarterly earnings report on Thursday, 2021-10-28. Here's what investors need to know before the announcement.
Analysts estimate that Abiomed will likely report an Earnings Per Share (EPS) of $0.97
Smallest Heart Pump From Abiomed Gets FDA Breakthrough Device Tag
The FDA has granted breakthrough device designation to Abiomed Inc’s (NASDAQ:ABMD) Impella ECP expandable percutaneous heart pump. Abiomed designed the Impella ECP…
Abiomed Says FDA Grants Breakthrough Device Designation To Co’s Impella
FDA Grants Breakthrough Device Designation to Impella ECP, the World's Smallest Heart Pump
The United States Food and Drug Administration (FDA) has granted breakthrough device designation to Abiomed's